Literature DB >> 9655281

Thyroid reoperations: indications and risks.

D B Wilson1, E D Staren, R A Prinz.   

Abstract

Thyroid reoperations can be technically difficult and associated with an increased risk of complications. To determine the indications for reoperations and the risk of postoperative complications with these procedures, records of 362 patients undergoing thyroidectomy by a single surgeon (R.A.P.) were reviewed. Thirty-two patients had a reoperation. The group consists of 21 women and 11 men with an average age of 55 years (range, 31-79). Twenty-four patients had 1 prior operation, and 8 patients had 2 or more. We performed 4 of the initial operations, and 28 were done by surgeons at other centers. Fourteen reoperations were done for symptomatic multinodular goiter (MNG), and 5 because of a change in the histologic diagnosis from benign to cancerous. The remainder were for further treatment of malignancy. The most common operation was completion thyroidectomy (31). In 3 patients, either unilateral or bilateral modified radical neck exploration was performed. One patient required median sternotomy. One subtotal thyroidectomy was also performed. Recurrent laryngeal nerve injury occurred in 2 patients. It resolved in 1 patient but was permanent in another, who had 3 operations for MNG. One of the 2 patients with preoperative unilateral vocal cord paralysis had return of function after removal of a substernal goiter. The other had a permanent nerve injury from the original surgery. Three patients had postoperative hypocalcemia (calcium <8.0 mg/dL). This resolved in all patients within 1 to 6 months. One patient who had a third operation for MNG had postoperative hemorrhage necessitating tracheostomy for airway control. Another patient developed a seroma that resolved within 2 months. We conclude that reoperations are indicated for both benign and malignant thyroid disease. Because they carry a higher risk of complications, every effort should be made to avoid them by performing definitive initial treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9655281

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  19 in total

1.  Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter.

Authors:  Marcin Barczyński; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Filip Gołkowski; Stanisław Cichoń; Wojciech Nowak
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 2.  Complications after reoperative thyroid surgery: retrospective evaluation of 152 consecutive cases.

Authors:  Fabio Medas; Massimiliano Tuveri; Gian Luigi Canu; Ernico Erdas; Pietro Giorgio Calò
Journal:  Updates Surg       Date:  2019-04-01

3.  Complications in primary and completed thyroidectomy.

Authors:  Michael Vaiman; Andrey Nagibin; Julian Olevson
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

4.  Comparison of surgical techniques for treatment of benign toxic multinodular goiter.

Authors:  Orhan Alimoglu; Murat Akdag; Mustafa Sahin; Cagatay Korkut; Ismail Okan; Neslihan Kurtulmus
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Recurrent laryngeal nerve injury and hypoparathyroidism rates in reoperative thyroid surgery.

Authors:  Mohamed Benkhadoura; Salah Taktuk; Reem Alobedi
Journal:  Turk J Surg       Date:  2017-03-01

6.  The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter.

Authors:  Serdar Tezelman; Ismail Borucu; Yasemin Senyurek Giles; Fatih Tunca; Tarik Terzioglu
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

7.  Tc-99m radio-guided completion thyroidectomy for differentiated thyroid carcinoma.

Authors:  Savaş Karyağar; Oğuzhan Karatepe; Omer Bender; Mehmet Mulazımoğlu; Tevfik Ozpaçaci; Ercan Uyanık; Sevda S Karyağar; Orhan Yalçın; Yaşar Ozdenkaya
Journal:  Indian J Nucl Med       Date:  2010-01

Review 8.  Prognostic utility of BRAF mutation in papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

9.  Intraoperative Frozen Biopsy of Central Lymph Node in the Management of Papillary Thyroid Microcarcinoma.

Authors:  Dong Hoon Lee; Tae Mi Yoon; Hee Kyung Kim; Joon Kyoo Lee; Ho Cheol Kang; Sang Chul Lim
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-09-15

10.  Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.

Authors:  Electron Kebebew; Miao Peng; Emily Reiff; Quan-Yang Duh; Orlo H Clark; Alex McMillan
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.